Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "Drug Discovery Informatics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.
The Global Drug Discovery Informatics Market, valued at USD 3.48 Billion in 2024, is projected to experience a CAGR of 9.40% to reach USD 5.97 Billion by 2030
Drug discovery informatics involves the application of computational methods and analytical tools to manage, analyze, and interpret the extensive and varied data generated throughout the drug discovery process, thereby enhancing the efficiency of identifying and optimizing potential drug candidates. The market's growth is primarily driven by substantial investments in pharmaceutical research and development, a necessity to process the increasing volume and complexity of scientific data, and the continuous pressure to reduce drug development timelines and associated costs. 
Key Market Drivers
The rapid proliferation of big data in drug discovery is a core driver accelerating the growth of the informatics market. The escalating volume and complexity of data generated from genomic sequencing, proteomics, and advanced experimental assays require sophisticated computational tools for effective data management, analysis, and interpretation.
This expanding data ecosystem is driving strong demand for informatics platforms capable of integrating diverse datasets and transforming them into actionable insights for identifying and prioritising potential drug candidates. Reflecting the scale of this data generation, the report Genomics Market Size, Trends and Tailored Solutions for Personalized Medicine stated that the global genomics market was valued at USD 38.52 billion in 2024, underscoring the magnitude of information being produced and the corresponding need for high-performance informatics solutions to accelerate early-stage drug development.
Key Market Challenges
The complexity of data integration and persistent interoperability challenges across fragmented platforms and heterogeneous data sources pose a significant constraint on the growth of the Global Drug Discovery Informatics Market. The pharmaceutical industry produces vast volumes of diverse data across multiple workflows, including genomics, proteomics, and clinical trials.
However, these datasets frequently remain siloed within disconnected systems, creating substantial barriers to standardisation, consolidation, and holistic analysis. This lack of seamless integration limits the ability to establish a unified and comprehensive research view, which is essential for accelerating drug candidate identification and optimisation.
Key Market Trends
The adoption of cloud-native informatics platforms represents a significant trend in the global drug discovery informatics market, moving away from on-premise infrastructure to scalable, accessible cloud-based solutions. This shift provides enhanced flexibility and computational power for managing and analyzing the vast datasets generated in drug discovery. According to a Pistoia Alliance survey published in September 2025, 80% of life sciences labs now utilize cloud data platforms, marking an increase from 70% in 2023. This growth underscores the industry's recognition of cloud benefits, including improved collaboration and reduced IT overheads.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $3.48 Billion |
| Forecasted Market Value (USD) by 2030 | $5.97 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
Report Scope:
Key Market Players Profiled:
- Dassault Systemes SE
- IBM Corporation
- Infosys Ltd.
- Schrodinger Inc.
- Jubilant Life Sciences NV
- Aragen Lifescience Ltd.
- Charles River Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Clarivate Analytics LLC
- PerkinElmer Inc.
By Mode:
- In-house
- Outsourced
By Workflow:
- Discovery
- Development
By Services:
- Sequence Analysis Platforms
- Molecular Modelling
- Docking
- Clinical Trial Data Management
- Others
By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROS)
- Others
By Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/ly18qt
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
